Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA fragmentation factor subunit beta pseudogene 1 (DFFBP1) is a processed pseudogene related to the DNA fragmentation factor subunit beta gene (DFFB), which encodes a protein critical for caspase-activated DNA fragmentation during apoptosis. As a pseudogene, DFFBP1 does not encode a functional protein product, nor does it have a demonstrated physiological, pathological, or therapeutic role. Unlike its parent gene DFFB, which is a true functional endonuclease (caspase-activated DNase), DFFBP1 is considered non-functional; its clinical or biological relevance is negligible unless further evidence arises indicating a regulatory noncoding RNA role, which is not currently documented for this locus. Existing data indicate that most such pseudogenes do not represent therapeutic targets, nor do they yield clinically relevant biomolecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA fragmentation factor subunit beta pseudogene 1 (DFFBP1).